Karen K. Giuliano is an associate professor, The Institute for Applied Life Sciences and College of Nursing, University of Massachusetts, Amherst.
Dian Baker is a professor, School of Nursing, California State University, Sacramento, California.
Am J Crit Care. 2020 Jan 1;29(1):9-14. doi: 10.4037/ajcc2020402.
Sepsis is a leading cause of mortality among hospitalized patients and is the most expensive condition affecting the US health care system. Pneumonia is associated with about half of sepsis cases, yet limited research has described the incidence of sepsis in the context of nonventilator hospital-acquired pneumonia (NV-HAP). Persons with NV-HAP who are at risk for sepsis must be identified so that interventions to reduce the burden of NV-HAP and improve outcomes among patients with sepsis can be designed.
To determine the proportion of persons with NV-HAP in whom sepsis develops and to describe the demographic and clinical characteristics of persons with NV-HAP in whom sepsis develops.
In this retrospective, population-based study, data were extracted from the National Inpatient Sample from the 2012 Healthcare Cost and Utilization Project dataset. International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify adult patients at least 18 years of age who had a stay of at least 48 hours, had no documented diagnosis of ventilator-associated pneumonia, and had secondary diagnoses of both NV-HAP and sepsis, neither of which was present on admission.
In the 2012 calendar year, 119 075 adults had NV-HAP develop; sepsis developed in 36.3% of these cases. Male and black patients were overrepresented in the sample, and patients had a mean of 7 comorbid conditions (SD, 3.3).
Sepsis in the context of NV-HAP is a key concern. Additional research is needed to identify factors associated with the development of sepsis among patients with NV-HAP.
败血症是住院患者死亡的主要原因,也是影响美国医疗保健系统成本最高的疾病。肺炎与大约一半的败血症病例有关,但有限的研究描述了非呼吸机获得性肺炎(NV-HAP)背景下败血症的发病率。必须确定有败血症风险的 NV-HAP 患者,以便设计减少 NV-HAP 负担和改善败血症患者预后的干预措施。
确定 NV-HAP 患者中发生败血症的比例,并描述发生败血症的 NV-HAP 患者的人口统计学和临床特征。
在这项回顾性、基于人群的研究中,从 2012 年医疗保健成本和利用项目数据集的国家住院患者样本中提取数据。使用国际疾病分类,第九版,临床修正版代码来识别至少 18 岁的成年患者,这些患者的住院时间至少为 48 小时,没有记录的呼吸机相关性肺炎诊断,并且有 NV-HAP 和败血症的二级诊断,这两种诊断都不是入院时就存在的。
在 2012 年的日历年中,有 119075 名成年人发生了 NV-HAP,其中 36.3%的人发生了败血症。男性和黑人患者在样本中占比过高,患者平均有 7 种合并症(SD,3.3)。
NV-HAP 背景下的败血症是一个关键问题。需要进一步研究来确定与 NV-HAP 患者发生败血症相关的因素。